These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24437244)

  • 1. [Combined treatment of patients with lower urinary tract symptoms and erectile dysfunction].
    Tomilov AA; Golubtsova EN
    Urologiia; 2013; (5):64-6, 68-9. PubMed ID: 24437244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined treatment of patients with erectile dysfunction and urination disorders].
    Kamalov AA; Osmolovskiĭ BE; Okhobotov DA; Khodyreva LA; Takhiradze TB; Takhiradze AM; Gevorkian AR
    Urologiia; 2013; (3):29-30, 32-3. PubMed ID: 23987045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia.
    Yokoyama T; Hara R; Fukumoto K; Fujii T; Jo Y; Miyaji Y; Nagai A; Sone A
    Int J Urol; 2011 Mar; 18(3):225-30. PubMed ID: 21272091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Zhao C; Kim SW; Yang DY; Kim JJ; Park NC; Lee SW; Paick JS; Ahn TY; Min KS; Park K; Park JK
    Eur Urol; 2011 Aug; 60(2):380-7. PubMed ID: 21458153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase 3 Study to Evaluate the 1-Year Efficacy and Safety of Udenafil 75 mg Once Daily in Patients With Erectile Dysfunction.
    Moon KH; Kim SW; Moon du G; Kim JJ; Park NC; Lee SW; Paick JS; Ahn TY; Chung WS; Min KS; Park JK; Yang DY; Shin HS; Park K
    J Sex Med; 2016 Aug; 13(8):1263-9. PubMed ID: 27319276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of combination therapy with mirodenafil and α1-blocker for benign prostatic hyperplasia-induced lower urinary tract symptoms accompanied by erectile dysfunction: a multicenter, open-label, prospective study.
    Lee JY; Cho SY; Oh CY; Ha US; Lee SH; Park SY; Moon HS; Lee SW
    Int J Impot Res; 2011; 23(6):249-56. PubMed ID: 21814227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction.
    Mulhall JP; Guhring P; Parker M; Hopps C
    J Sex Med; 2006 Jul; 3(4):662-667. PubMed ID: 16839322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind study.
    Giuliano F; Oelke M; Jungwirth A; Hatzimouratidis K; Watts S; Cox D; Viktrup L
    J Sex Med; 2013 Mar; 10(3):857-65. PubMed ID: 23346990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of tamsulosin vs tamsulosin/sildenafil effectiveness in the treatment of erectile dysfunction in patients affected by type III chronic prostatitis.
    Cantoro U; Catanzariti F; Lacetera V; Quaresima L; Muzzonigro G; Polito M
    Arch Ital Urol Androl; 2013 Sep; 85(3):109-12. PubMed ID: 24085230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of udenafil for the treatment of erectile dysfunction up to 12 hours after dosing: a randomized placebo-controlled trial.
    Park HJ; Park JK; Park K; Min K; Park NC
    J Sex Med; 2010 Jun; 7(6):2209-2216. PubMed ID: 20412426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction.
    Park SH; Park SW; Cha BY; Park IeB; Min KW; Sung YA; Kim TH; Lee JM; Park KS
    Asian J Androl; 2015; 17(1):143-8. PubMed ID: 25155105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with doxazosin and tenoxicam for the management of lower urinary tract symptoms.
    Ozdemir I; Bozkurt O; Demir O; Aslan G; Esen AA
    Urology; 2009 Aug; 74(2):431-5. PubMed ID: 19501883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, placebo-controlled study to assess safety and efficacy of vardenafil 10 mg and tamsulosin 0.4 mg vs. tamsulosin 0.4 mg alone in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Gacci M; Vittori G; Tosi N; Siena G; Rossetti MA; Lapini A; Vignozzi L; Serni S; Maggi M; Carini M
    J Sex Med; 2012 Jun; 9(6):1624-33. PubMed ID: 22510238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of repeated dosing with Udenafil (Zydena) on cognition, somatization and erection in patients with erectile dysfunction: a pilot study.
    Shim YS; Pae CU; Kim SW; Kim HW; Kim JC; Koh JS
    Int J Impot Res; 2011; 23(3):109-14. PubMed ID: 21544084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction.
    Seftel AD
    J Urol; 2015 Apr; 193(4):1326. PubMed ID: 25890547
    [No Abstract]   [Full Text] [Related]  

  • 16. Commentary on - "Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction".
    Cao DH; Liu LR; Wei Q
    Asian J Androl; 2015; 17(5):854. PubMed ID: 25652635
    [No Abstract]   [Full Text] [Related]  

  • 17. Tadalafil versus solifenacin for persistent storage symptoms after prostate surgery in patients with erectile dysfunction: a prospective randomized study.
    Maselli G; Bergamasco L; Silvestri V; Gualà L; Pace G; Vicentini C
    Int J Urol; 2011 Jul; 18(7):515-20. PubMed ID: 21592232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tadalafil in patients with benign prostatic hyperplasia during conservative combined therapy].
    Volkov AA; Petrichko MI; Budnik NV; Dukhin AR
    Urologiia; 2013; (2):56, 58-9. PubMed ID: 23789365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of once daily administration of 50 mg mirodenafil in patients with erectile dysfunction: a multicenter, double-blind, placebo controlled trial.
    Chung JH; Kang DH; Oh CY; Chung JM; Lee KS; Kim TH; Moon KH; Lee W; Cho JM; Lee SW
    J Urol; 2013 Mar; 189(3):1006-13. PubMed ID: 23017527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy.
    Fwu CW; Eggers PW; Kirkali Z; McVary KT; Burrows PK; Kusek JW
    J Urol; 2014 Jun; 191(6):1828-34. PubMed ID: 24342143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.